tiprankstipranks
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market

Symbio Pharmaceuticals Limited (4582) Financial Statements

Compare
1 Followers

Symbio Pharmaceuticals Limited Financial Overview

Symbio Pharmaceuticals Limited's market cap is currently ¥8.45B. The company's EPS TTM is ¥-84.723; its P/E ratio is ―; Symbio Pharmaceuticals Limited is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 5.59B¥ 10.01B¥ 8.25B¥ 2.99B¥ 2.84B
Gross Profit¥ 4.41B¥ 7.60B¥ 5.80B¥ 866.85M¥ 864.75M
Operating Income¥ -811.67M¥ 1.96B¥ 1.02B¥ -4.51B¥ -4.30B
EBITDA¥ -714.00M¥ 2.20B¥ 1.11B¥ -4.44B¥ -4.26B
Net Income¥ -1.96B¥ 1.18B¥ 2.03B¥ -4.09B¥ -4.38B
Balance Sheet
Cash & Short-Term Investments¥ 6.52B¥ 6.28B¥ 3.86B¥ 3.85B¥ 3.91B
Total Assets¥ 8.17B¥ 10.43B¥ 8.45B¥ 6.27B¥ 5.27B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -6.52B¥ -6.28B¥ -3.86B¥ -3.85B¥ -3.91B
Total Liabilities¥ 960.33M¥ 1.93B¥ 1.71B¥ 1.62B¥ 873.84M
Stockholders' Equity¥ 7.21B¥ 8.51B¥ 6.75B¥ 4.66B¥ 4.40B
Cash Flow
Free Cash Flow¥ -427.48M¥ 1.57B¥ 76.20M¥ -4.27B¥ -4.57B
Operating Cash Flow¥ -194.69M¥ 1.61B¥ 140.04M¥ -4.12B¥ -4.35B
Investing Cash Flow¥ -376.70M¥ -47.13M¥ -70.85M¥ -160.31M¥ -216.46M
Financing Cash Flow¥ 680.16M¥ 627.99M¥ -71.92M¥ 4.22B¥ 3.74B
Currency in JPY

Symbio Pharmaceuticals Limited Earnings and Revenue History

Symbio Pharmaceuticals Limited Debt to Assets

Symbio Pharmaceuticals Limited Cash Flow

Symbio Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis